Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing
Following a filing revealing its intent to go public in the US on 6 January, artificial pancreas maker Beta Bionics…
Diabetes Care Devices
-
-
How Dexcom and ŌURA are unifying two distinct market sectors
Technology has come a long way since the first blood glucose meter was developed by Anton H Clemens in 1965.…
-
JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue
Dexcom has shaken off the lower sales outlook that plagued its share price in 2024 as the diabetes device developer…
-
Dexcom implements GenAI into glucose biosensor devices
The applications of generative artificial intelligence (GenAI) have reached continuous glucose monitoring after DexCom launched rolled out the technology into…
-
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster
Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod pump is…
-
Medtronic’s insulin pen app gains FDA clearance
Medtronic has received clearance from the US Food and Drug Administration (FDA) for its new InPen app, paving the way…
-
Dexcom invests $75m in ŌURA to forge partnership
Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim…
-
ReShape secures NIH grant to develop electrodes for diabetes treatment device
ReShape Lifesciences has received a $241,000 grant from the US National Institutes of Health (NIH) to develop electrodes for its…
-
Insulet rolls out iPhone app for Omnipod 5 insulin pump in US
Insulet has launched the Omnipod 5 automated insulin delivery app for iPhone in the US. The app obviates the need…
-
Luna Diabetes trials automated wearable insulin pump
US-based device company Luna Diabetes has initiated a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System, in…
